Pfizer Slaps Teva With Suit Over Zyvox ANDA

Law360, New York (January 19, 2010, 1:21 PM EST) -- Pfizer Inc. has hauled Teva Pharmaceutical Industries Ltd. into court in a bid to halt the generics maker's application to manufacture a version of the antibiotic Zyvox, the subject of ongoing litigation over allegations of off-label promotion.

In a complaint lodged Friday in the U.S. District Court for the District of Delaware, Pfizer claims that Teva, its Teva Parenteral Medicines Inc. unit and its U.S. subsidiary have infringed a patent for the antibiotic by filing an abbreviated new drug application with the U.S. Food and Drug...
To view the full article, register now.